CME Group Inc. (NASDAQ:CME) Shares Bought by Capital Counsel LLC NY

Capital Counsel LLC NY lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 0.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 829,324 shares of the financial services provider’s stock after purchasing an additional 3,986 shares during the period. CME Group comprises about 7.9% of Capital Counsel LLC NY’s holdings, making the stock its 9th largest position. Capital Counsel LLC NY’s holdings in CME Group were worth $182,990,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Harbor Capital Advisors Inc. increased its stake in CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC increased its stake in CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich boosted its position in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares in the last quarter. Zions Bancorporation N.A. boosted its position in shares of CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after buying an additional 54 shares in the last quarter. Finally, Quent Capital LLC grew its stake in CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CME. Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research report on Thursday, October 24th. Morgan Stanley upped their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Piper Sandler upped their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $224.47.

Insider Transactions at CME Group

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 1.57 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 over the last quarter. Company insiders own 0.30% of the company’s stock.

CME Group Stock Up 2.2 %

CME opened at $234.39 on Wednesday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $235.18. The firm has a 50 day moving average price of $224.18 and a 200 day moving average price of $211.37. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market cap of $84.46 billion, a PE ratio of 24.65, a price-to-earnings-growth ratio of 5.29 and a beta of 0.55.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.25 earnings per share. Sell-side analysts expect that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.